ZyVersa Therapeutics, Inc. Profile Avatar - Palmy Investing

ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segm…

Biotechnology
US, Weston [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ZVSA's Analysis
CIK: - CUSIP: - ISIN: US98987D2018 LEI: - UEI: -
Secondary Listings
ZVSA has no secondary listings inside our databases.